etoposide has been researched along with B-Cell Leukemia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auperin, A; Baruchel, A; Bergeron, C; Bertrand, Y; Coze, C; Lacombe, MJ; Lervat, C; Leverger, G; Méchinaud, F; Munzer, M; Nelken, B; Patte, C | 1 |
| Blazejczyk, A; Dziegiel, P; Dzimira, S; Hildebrand, W; Krupa, A; Kutkowska, J; Obminska-Mrukowicz, B; Pawlak, A; Rapak, A; Strzadala, L; Wietrzyk, J; Ziolo, E | 1 |
| Cortes, JE; Estrov, Z; Ferrajoli, A; Garcia-Manero, G; Jabbour, E; Kantarjian, HM; Khouri, M; Khoury, JD; Ko, H; O'Brien, SM; Pierce, S; Ravandi, F; Short, NJ; Thomas, DA; Thompson, PA; Verstovsek, S; Wierda, WG | 1 |
| Barnich, M; Cairo, M; Chang, M; Griffin, TC; Gross, TG; Hutchison, R; Shiramizu, B; Weinstein, H; Weitzman, S; Wiley, J; Woods, D | 1 |
| Adams, S; Davis, S; Fortney, JE; Gibson, LF; Hall, BM; Taylor, L; Wang, L; Wood, H | 1 |
| Godwin, JE; Yuen, BH | 1 |
| Balkenende, AY; Slaper-Cortenbach, IC; van den Berg, H; van der Schoot, CE; Van Leeuwen, EF; Vervoordeldonk, SF; von dem Borne, AE | 1 |
| Driscoll, TA; Hannun, YA; Obeid, LM; Zhang, J | 1 |
| Bhalla, K; Bullock, G; Huang, Y; Maria Ibrado, A; Miyashita, T; Ray, S; Reed, J | 1 |
| Bantel, H; Engels, IH; Schulze-Osthoff, K; Voelter, W; Wesselborg, S | 1 |
| Fortney, JE; Gibson, LF; Hall, BM; Mudry, RE; York, T | 1 |
1 trial(s) available for etoposide and B-Cell Leukemia
| Article | Year |
|---|---|
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Ifosfamide; Leukemia, B-Cell; Lymphoma, B-Cell; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Treatment Outcome; Young Adult | 2009 |
10 other study(ies) available for etoposide and B-Cell Leukemia
| Article | Year |
|---|---|
Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 study.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hydrocortisone; Infant; L-Lactate Dehydrogenase; Leucovorin; Leukemia, B-Cell; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Prednisone; Vincristine | 2014 |
A novel canine B-cell leukaemia cell line. Establishment, characterisation and sensitivity to chemotherapeutics.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Blotting, Western; Celecoxib; Cell Line, Tumor; Dexamethasone; Dog Diseases; Dogs; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Imatinib Mesylate; Leukemia, B-Cell; Mice; Neoplasm Transplantation; Piroxicam | 2017 |
Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma.
Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Leukemia, B-Cell; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Methotrexate; Polyethylene Glycols; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Treatment Outcome; Vincristine | 2017 |
Stromal cells expressing elevated VCAM-1 enhance survival of B lineage tumor cells.
Topics: Animals; Antineoplastic Agents; Bone Marrow Cells; Cell Survival; Coculture Techniques; Etoposide; Humans; Leukemia, B-Cell; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-bcl-2; Stromal Cells; Tumor Cells, Cultured; Vascular Cell Adhesion Molecule-1 | 2004 |
ProMACE day 1/MOPP day 8 chemotherapy for prolymphocytic leukemia: a case report of prolonged survival.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, B-Cell; Leukemia, Prolymphocytic; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Time Factors; Vincristine | 1994 |
Degradation of radioiodinated B cell monoclonal antibodies: inhibition via a FCgamma-receptor-II-mediated mechanism and by drugs.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Antigens, CD19; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Agents; B-Lymphocytes; Biological Transport; Burkitt Lymphoma; Calcium Channel Blockers; Cell Adhesion Molecules; Chloroquine; Colchicine; Etoposide; Humans; Immunoglobulin Isotypes; Immunotoxins; Iodine Radioisotopes; Lectins; Leukemia, B-Cell; Mice; Monensin; Paclitaxel; Radioimmunotherapy; Receptors, IgG; Sialic Acid Binding Ig-like Lectin 2; Verapamil; Vinblastine; Vincristine | 1996 |
Regulation of membrane release in apoptosis.
Topics: Apoptosis; Arachidonic Acid; Cell Membrane; Cysteine Proteinase Inhibitors; Etoposide; HL-60 Cells; Humans; Kinetics; Leukemia, B-Cell; Membrane Lipids; Palmitic Acid; Phospholipases A; Phospholipases A2; Preleukemia; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Sphingosine; Transfection; Tumor Cells, Cultured; Vincristine | 1998 |
Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Cisplatin; Cytarabine; Etoposide; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Genes, jun; HL-60 Cells; Humans; Leukemia, B-Cell; Mitoxantrone; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-jun; Recombinant Proteins; Transfection; Tumor Cells, Cultured | 1995 |
Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis.
Topics: Amino Acid Chloromethyl Ketones; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptotic Protease-Activating Factor 1; Arabidopsis Proteins; Brefeldin A; Caspase 3; Caspase 8; Caspase 9; Caspases; Cysteine Proteinase Inhibitors; Cytochrome c Group; Drug Synergism; Enzyme Activation; Enzyme Precursors; Etoposide; fas Receptor; Fatty Acid Desaturases; Humans; Jurkat Cells; Leukemia-Lymphoma, Adult T-Cell; Leukemia, B-Cell; Mitochondria; Mitomycin; Neoplasm Proteins; Plant Preparations; Plant Proteins; Proteins; Ribosome Inactivating Proteins, Type 2; Toxins, Biological; Tumor Cells, Cultured | 1999 |
Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy.
Topics: Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Cell Cycle; Cell Death; Cell Survival; Coculture Techniques; Culture Media, Conditioned; Cytarabine; Etoposide; Fibronectins; Humans; Jurkat Cells; Kinetics; Leukemia, B-Cell; Membrane Proteins; Protein Binding; Signal Transduction; Stromal Cells; Time Factors; Tumor Cells, Cultured; Vascular Cell Adhesion Molecule-1 | 2000 |